Ferran Nadeu/LinkedIn
Oct 22, 2025, 10:46
Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
Touch Medical Media shared on LinkedIn:
”A Conversation with Dr Ferran Nadeu – Touch Haematology Future Leaders 2025
As part of our Future Leaders 2025 series, we spoke with Dr Ferran Nadeu (Hospital Clínic de Barcelona, Spain) about his journey in cancer genomics and haematology.
In this interview, he reflects on the influence of mentorship, the excitement of translational discoveries, and how emerging genomic technologies are transforming our understanding of B-cell malignancies.
Read the full interview.”
More winner stories featured in Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025